January 13, 2026
Headlines

cough syrup deaths

After cough syrup deaths, drug regulator moves to tighten rules on high-risk solvents; unlicensed village pharmacies also under scrutiny

DRRA03 mins

[ad_1] India’s drug regulator is looking at various ways to verify the quality of high-risk solvents, such as propylene glycol, used for making liquid oral formulations, in the wake of multiple incidents of contaminated cough syrups leading to children’s death. The drug regulatory authority is also considering stopping sale of cough syrups by non-licensed pharmacists…

Read More

Cough Syrup deaths: Sresan Pharmaceuticals’ license cancelled, company shut down

DRRA02 mins

[ad_1] Chennai: Tamil Nadu Drugs Control Department on Monday announced the cancellation of the manufacturing license of Sresan Pharmaceutical company, the manufacturer of Coldrif cough syrup, linked with deaths of at least 22 people in Madhya Pradesh. The state health department stated that the company has been officially shut down after its investigation of toxic…

Read More

Cough syrup deaths: CDSCO launches risk-based inspection at manufacturing units of 19 drugs

DRRA02 mins

[ad_1] Central drug regulator, CDSCO, has initiated risk-based inspection at the manufacturing units of 19 drugs, including cough syrups and antibiotics, across six states following reports of child deaths due to the consumption of contaminated cough syrup in Madhya Pradesh, the health ministry said on Saturday. The inspections by the Central Drugs Standard Control Organisation…

Read More